12:00 AM
Jun 25, 2012
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Activist investor Carl Icahn unveiled the three individuals that will join Eric Ende on Icahn's slate of nominees for the board of Forest Laboratories. Last month, Icahn named Ende as the first nominee. Icahn said the other nominees are Andrew Fromkin, former president and CEO of Clinical Data Inc., which Forest acquired last year; Pierre...

Read the full 261 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >